期刊文献+

低分子肝素治疗新生儿脓毒症合并DIC48例临床疗效观察 被引量:8

下载PDF
导出
摘要 目的探讨低分子肝素(LMWH)治疗新生儿脓毒症合并弥散性血管内凝血(DIC)的临床疗效。方法随机选取我院收治的新生儿脓毒症并DIC患儿48例作为观察对象,按照随机数表法分为观察组与对照组各24例。对照组采用包括抗感染、基础支持、营养供应、热量供应、水电解质紊乱及酸碱平衡紊乱调节及呼吸机辅助呼吸等常规治疗,观察组患者在常规治疗的基础上加用低分子肝素进行治疗,观察2组治疗效果并进行对比和分析。结果观察组在治愈率、出血停止时间、DIC纠正时间、出血加重病例等方面与对照组比较,差异有统计学意义(P值均<0.05)。结论低分子肝素治疗新生儿脓毒症并DIC对比常规治疗效果显著。
作者 武梦骅
出处 《淮海医药》 CAS 2015年第2期182-183,共2页 Journal of Huaihai Medicine
  • 相关文献

参考文献4

二级参考文献22

  • 1姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3):185-186. 被引量:118
  • 2艾宇航,张丽娜,龚华,徐道妙,赵双平,陈江辉.低分子肝素治疗脓毒症的前瞻性临床研究[J].中国危重病急救医学,2005,17(12):736-739. 被引量:43
  • 3Kinasewitz GT,Yah SB,Basson B,et al.Universal changes in biomarkels of coagulation and inflammation occur in patients with severe sepsis regardless of causative micro-organism[J].Crit Care,2004,8(2):82-90.
  • 4Levy MM,Fink MP,Marshall JC,et al.200l SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conferencel[J].Intensive Care Med,2003,29(4):530-538.
  • 5Bellomo R,Wan L,Langenberg C,et al.Septic acute kidney injury:new concepts[J].Nephron Exp Nephrol,2008,109(4):e95-100.
  • 6Baranyai R,Nonell A,Deuschle M,et al.How depression may increase cardiac risk:Effect of hypercortisolism on platelet activation markers Prelim inary data[J].Neuropsychobiology,2008,57(3):146-150.
  • 7Black GJ,Ridker PM.Novel clinical markers of vascular wall inflammation[J].Circ Res,2001,89(9):763-771.
  • 8曹亚珍,吕新湖.低分子肝素与普通肝素在择期PCI中抗凝效果比较[D].石家庄:河北医科大学,2010.
  • 9张志成,邹曰坤,段蕴铀,刘于红,李大伟,王爱丽,帅维正,单毅,张萍.低分子肝素早期治疗脓毒症临床研究[J].山东医药,2008,48(9):102-103. 被引量:8
  • 10卢骁,赵良.低分子肝素防治脓毒症机制的研究进展[J].中国急救医学,2008,28(11):1033-1036. 被引量:3

共引文献584

同被引文献57

  • 1廖梅嫣,黄滔,曾汇霞,吴海宾,潘朝勇,吴家圣,钟友娣.早期使用低分子肝素预防性抗凝治疗对脓毒症患者临床疗效的影响研究[J].智慧健康,2020(16):160-162. 被引量:2
  • 2White RH. The epidemiology of venous thromboembolism. Circula- tion, 2003, 107(23 Suppl 1): 14-18.
  • 3Lyta, yn OI, Kopitsa MP, Petyunina OV. Interaction between inflam- mation and thrombosis in acute coronary syndrome. Kardiol Pol, 2004, 61(8): 110-116.
  • 4Salobir B, Sabovic M. Possible vascular-bed-specific role of inter- leukin-6 in young women with a history of myocardial infarction, lacunar cerebral infarction and deep vein thrombosis. Cytokine, 2004, 25(6): 265-272.
  • 5Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res, 2004, 114(5): 321-327.
  • 6van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol, 2002, 116(1): 173-177.
  • 7Kaplanski G, Fahrigoule M, Boulay V, et al. Thrombin induces endo- thelial type lJ activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression. J Immunol, 1997, 158(11): 5435-5441.
  • 8Wan MX, Zhang XW, TSrkvist L, et al. Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling, lnflarnm Res, 2001, 50(12): 581-584.
  • 9Celasco G, Moro L, Bozzella R, et al. Efficacy ofintracolonic admini- stration of low-molecular-weight heparin CB-01-05, compared to other low-molecular-weight heparins and unfractionated heparin, in experimentally induced colitis in rat. Dig Dis Sci, 2008, 53(12): 3170- 3175.
  • 10Papa A, Danese S, Gasbarrini A, et al. Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease. Aliment Pharmacol Ther, 2000, 14(11): 1403-1409.

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部